| AP-1 | AP-2 | AP-3 | (n) |
---|
B1 | 75.6% | 73.7% | 45.3% | (145) |
(35) | (53) | (57) |
B23 | 57.1% | 65.6% | 43.0% | (100) |
(25) | (27) | (48) |
B4over | 60.0% | 34.7% | 21.3% | (52) |
(5) | (19) | (28) |
(n) | (65) | (99) | (133) | (297) |
- AP-factor, a product of the serum levels of AFP and PIVKA-II. HCC patients were classified into three groups: AP1 (AFP < 200 ng/ml and PIVKA-II < 100 mAU/ml), AP2 (AFP × PIVKA-II < 105), and AP3 (AFP × PIVKA-II ≥ 105). B1, B23, and B4over were classified by tumor numbers 1, 2 or 3, and ≥4, respectively. Group A comprises B1 or B23 and AP-1 or AP-2. Group B comprises B1 or B23 and AP-3, or B4over and AP-1 or AP-2. Group C comprises B4over and AP-3